NCT06773377View on ClinicalTrials.gov

Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma

Not yet recruitingOBSERVATIONAL

Enrollment

77

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

December 1, 2026

Conditions

Renal Cell Cancer

All Listed Sponsors

lead

Assiut University

OTHER